Skip to main content

InvestorNewsBreaks – Grey Cloak Tech Inc. (GRCK) Announces Exceptional Results from Its Pilot Migraine Study

Grey Cloak Tech (OTCQB: GRCK) (soon to be Healthy Extracts Inc.), a company engaged in proprietary development of natural plant-based formulations and sales and distribution of cardiovascular and neuro products, today announced that its subsidiary, Ultimate Brain Nutrients(TM) (“UBN”), demonstrated exceptional results from its pilot migraine study* for its proprietary Fuel4Thought(TM) (F4T(TM)) formulation. “We all know someone who suffers from migraines with over 40 million people affected in just the United States,” stated Duke Pitts, GRCK president. “This pilot study shows that the F4T(TM) formulation could provide a natural non-prescription alternative that is totally unique in today’s marketplace and will join our current F4T(TM) Brain Booster in 2021. These two products will be a significant part of attaining our sales goals in the future.”

To view the full press release, visit https://ibn.fm/UPNiS

About Grey Cloak Tech Inc. 

Grey Cloak Tech (name change pending to Healthy Extracts Inc.), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (“UBN”), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company’s websites: www.HealthyExtractsInc.comwww.BergametNA.comwww.UBNutrients.com.

*Full Published Details of the Pilot Study – This background experience provided the platform from which we developed a definitive longer term, randomized, prospective, double-blind, placebo-controlled trial design to be initiated early in 2021 in a larger group of migraine sufferers.

NOTE TO INVESTORS: The latest news and updates relating to GRCK are available in the company’s newsroom at http://ibn.fm/GRCK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.